SEC Form EFFECT filed by Entera Bio Ltd.
$ENTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | June 6, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||